Aristotle

Dec 2024 → Jun 2026 · Publishes quarterly · 15 funds

Our archive holds 49 letters from Aristotle, behind 85 investment theses. Every quote below is copied verbatim from the letter it came from.

Aristotle’s own letters page

Letters

Companies

Moves

Theses

Theses · 85

Wal-Mart de Mexico SAB de CV
June 2026
Wal-Mart de Mexico combines dominant scale, omnichannel growth, strong ROIC, and valuation upside from store expansion and margin gains.
Read the full thesis
Techtronic Industries Co. Ltd.
June 2026
Techtronic Industries is a leading power-tool franchise with strong brands, a battery ecosystem moat, attractive valuation, and multiple growth catalysts.
Read the full thesis
Jazz Pharmaceuticals
June 2026
Jazz Pharmaceuticals is building long-term value through differentiated therapies, a growing oncology franchise, and strong cash flow generation.
Read the full thesis
Qualcomm
June 2026
Qualcomm is diversifying beyond handsets into connected computing, benefiting from AI and connectivity tailwinds while generating strong free cash flow.
Read the full thesis
Danaher
June 2026
Danaher is a disciplined healthcare platform with recurring revenue, strong capital allocation, and a culture that supports margin expansion and free cash flow.
Read the full thesis
The Magnum Ice Cream Company N.V.
June 2026
The Magnum Ice Cream Company is a global ice cream leader with premium brands, a hard-to-replicate cold-chain network, and attractive valuation.
Read the full thesis
Techtronic Industries
June 2026
Techtronic Industries is building a sticky power-tool ecosystem led by Milwaukee and Ryobi with expanding professional end-markets.
Read the full thesis
The Magnum Ice Cream Company N.V.
June 2026
The Magnum Ice Cream Company has multiple growth catalysts around distribution expansion, premiumization, and operational improvement.
Read the full thesis
Accenture
June 2026
Accenture is a scaled enterprise transformation partner with broad AI, cybersecurity, and mid-market growth opportunities.
Read the full thesis
Immunome Inc.
March 2026
Immunome Inc. is a biotech led by experienced management with a desmoid tumor therapy nearing FDA filing, sizable market potential, and ample cash.
Read the full thesis
Amphenol Corporation
March 2026
Amphenol is a diversified interconnect and sensor leader benefiting from secular tailwinds like AI data centers and electrification, with M&A discipline and operational excellence supporting margins and free cash flow.
Read the full thesis
Envista Holdings
March 2026
Envista Holdings is a diversified dental products company positioned in a resilient, growing end market with margin recovery potential at an attractive valuation.
Read the full thesis

Showing the 48 most recent of 85 theses. Browse them by company to see the rest.

Letter archive · 49

2026

2025

2024

Funds · 15

Aristotle International Equity9
Aristotle Core Equity5
Aristotle Global Equity5
Aristotle Small Mid Cap Equity5
Aristotle Value Equity5
Aristotle Large Cap Growth4
Aristotle Small Cap Equity3
Aristotle Capital Core Equity2
Aristotle Capital International Equity2
Aristotle Capital Large Cap Growth2
Aristotle Capital Small Cap Equity2
Aristotle Focus Growth2
Aristotle Focus Growth Equity1
Aristotle Global Equity Advisory1
Aristotle Large Cap Growth Equity1

Get Aristotle’s next letter the day it lands

We track Aristotle alongside hundreds of other managers, read every letter, and pull out what they bought and sold. Warren AI reads the whole archive for you.

View plans→

Share this fund